Cartesian Therapeutics (RNAC) Interest Coverage Ratio (QoQ) (2015 - 2023)
Cartesian Therapeutics (RNAC) Interest Coverage Ratio (QoQ) (2015 - 2023) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Cartesian Therapeutics |
261.84 Mn |
261.84 Mn |
- |
| Date | Value |
| Sep 30, 2023 |
58.59% |
| Jun 30, 2023 |
-8.95% |
| Mar 31, 2023 |
-116.08% |
| Dec 31, 2022 |
-428.04% |
| Sep 30, 2022 |
-110.29% |
| Jun 30, 2022 |
27.22% |
| Mar 31, 2022 |
165.67% |
| Dec 31, 2021 |
307.11% |
| Sep 30, 2021 |
-535.62% |
| Jun 30, 2021 |
106.31% |
| Mar 31, 2021 |
9.11% |
| Dec 31, 2020 |
70.56% |
| Sep 30, 2020 |
52.87% |
| Jun 30, 2020 |
-15.80% |
| Mar 31, 2020 |
-83.74% |
| Dec 31, 2019 |
-23.44% |
| Sep 30, 2019 |
25.11% |
| Jun 30, 2019 |
-35.57% |
| Mar 31, 2019 |
-101.24% |
| Dec 31, 2018 |
5,921.07% |